Nav: Home

Hepatitis C-infected kidneys function as well as uninfected organs after transplant

September 12, 2019

PHILADELPHIA -- Kidneys from donors who were infected with the Hepatitis C virus (HCV) function just as well as uninfected kidneys throughout the first year following transplantation, according to a new Penn Medicine study. The analysis of kidney transplant recipients across the United States, published today in the Journal of the American Society of Nephrology, also revealed a threefold increase in the number of transplant centers using HCV-infected kidneys and a major change in how the organs are allocated.

Prior to September 2018, the majority of HCV-infected organs were transplanted into patients who already had HCV infection. Since then, however, nearly 75 percent of the patients who were transplanted with HCV-infected kidneys did not already have the virus. Researchers reported similar one-year outcomes for both groups of patients. Despite the increased use of HCV-infected organs and promising outcomes, the Kidney Donor Profile Index (KDPI) Calculator - which combines a variety of donor factors to summarize the likelihood of organ failure after deceased donor transplant - still assigns much worse risk scores to organs from HCV-positive donors.

"These striking results provide additional evidence that the KDPI does not accurately assess the quality of kidneys from HCV-positive donors," said the study's corresponding author Peter Reese, MD, MSCE, an associate professor of Medicine and Epidemiology. "Rescaling the index to reflect these positive outcomes might lead clinicians to offer these kidneys to younger patients with longer life expectancy, when clinically appropriate, and could help expand access for the nearly 100,000 Americans awaiting a kidney transplant."

For decades, most HCV-infected organs in the United States were discarded partly because of concerns that the organs were associated with significantly lower survival rates. However, in recent years, the emergence of new antiviral treatments, coupled with the growing need for kidney transplants, prompted the launch of new studies to test the safety and efficacy of transplanting HCV-infected kidneys into patients on the waitlist who did not have the virus. The studies, including a trailblazing clinical trial launched by Penn Medicine in 2016, revealed that the use of HCV-infected kidneys - when followed by antiviral therapy - can lead to very good transplant outcomes for patients.

However, questions remained about whether the HCV-infected organs would function comparably to similar uninfected kidneys - particularly in patients who did not have the virus - and whether the promising results of the single-center studies would be confirmed in a larger, nationwide study.

A team of researchers, led by Reese and Vishnu Potluri, MD, MPH, an instructor of Nephrology at Penn, analyzed national transplant registry data to examine the use of HCV-infected kidneys between April 2015 and March 2019. To measure how well the kidneys functioned compared to uninfected kidneys, researchers designed highly-similar matched sets, in which the donors had nearly identical qualities - including age, weight and history of high blood pressure - except for HCV status. Researchers then used a widely-used mathematical formula, called the Chronic Kidney Disease Epidemiology Collaboration equation, to estimate each recipient's glomerular filtration rate (eGFR) - a measure that determines how well the blood is filtered by the kidneys. The lower the GFR number, the worse the kidney function. For example, having a GFR below 60 is abnormal. In their analysis, researchers found that recipients who received HCV-infected kidneys had an eGFR of 66.3 at the one-year mark. Patients who received uninfected kidneys had an eGFR of 67.1.

In addition to finding HCV-infected kidneys functioned similarly to uninfected kidneys, the team found transplant centers and patients were increasingly willing to accept the organs. For example, the number of transplant centers using HCV-infected kidneys jumped from 11 in 2015 to 39 centers through the first three months of 2019. Despite the increased acceptance and use of these kidneys, researchers found that nearly 40 percent of the HCV-infected kidneys donated between January 2018 and March 2019 were discarded.

"While the discard rate of these organs has declined in recent years, our findings suggest there is still substantial opportunity to expand the use of HCV-infected organs," said Potluri, the study's lead author. "Our results suggest we should make it a priority to maximize the use of good-quality HCV-infected organs."
Additional Penn Medicine authors include David S. Goldberg, Roy D. Bloom, Deirdre Sawinski, Peter L. Abt, Emily A. Blumberg and K. Rajender Reddy.

The work was supported, in part, by a Ben J. Lipps grant from the American Society of Nephrology.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $425 million awarded in the 2018 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center--which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report--Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation's first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Home Care and Hospice Services, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 40,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2018, Penn Medicine provided more than $525 million to benefit our community.

University of Pennsylvania School of Medicine

Related Kidney Transplant Articles:

The economic burden of kidney transplant failure in the United States
A recent analysis published in the American Journal of Transplantation estimates that for the average US patient who has undergone kidney transplantation, failure of the transplanted organ (graft failure) will impose additional medical costs of $78,079 and a loss of 1.66 quality-adjusted life years.
Mixed chimerism improves long-term kidney transplant outlook
Mixed chimerism - the continued mixing of donor and recipient blood cells following a transplant of blood progenitor cells - could improve outcomes for kidney transplant recipients, according to a new clinical study in about 50 patients.
Kidney paired donation is an excellent option for transplant candidates
An analysis compared transplant recipients who received kidneys through national kidney paired donation and those who received kidneys from other living donors (such as relatives, friends or other paired exchange mechanisms).
Mediterranean diet may help preserve the kidney health of transplant recipients
In a study of kidney transplant recipients, those with higher adherence to the Mediterranean diet were less likely to experience kidney function loss.
New blood test can detect rejection by antibodies after kidney transplant
A group of European scientists led by KU Leuven has found a biomarker that can identify patients with symptoms of kidney rejection symptoms after a transplant as a result of antibodies.
Measuring quality of life after pediatric kidney transplant
After receiving a kidney transplant, children may experience worrisome quality-of-life changes that underscore the importance of screening transplant recipients for psychosocial function, according to Children's research presented during the 10th Congress of the International Pediatric Transplant Association.
dnDSA and ethnicity linked with thickening of blood vessels after kidney transplant
Children who developed anti-human leukocyte antibodies against their donor kidney, known as de novo donor-specific antibodies, were more likely to experience carotid intima-media thickening than those without these antibodies, according to preliminary research presented May 7, 2019, during the 10th Congress of the International Pediatric Transplant Association.
Kidney transplant patients need even better aftercare!
Kidney transplantation is the best renal replacement therapy available. Although survival and quality of life are significantly better compared to dialysis patients, transplant recipients nevertheless have a significantly higher cardiovascular morbidity and mortality than healthy people.
Marijuana use has no effect on kidney transplant outcomes
A new study published in Clinical Kidney Journal indicates that the usage of marijuana by kidney donors has no measurable effect upon the outcomes of kidney transplants for donors or recipients.
Frailty may lower kidney failure patients' likelihood of receiving a transplant
Frailty is associated with decreased access at multiple stages in the pathway to kidney transplantation.
More Kidney Transplant News and Kidney Transplant Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

One of the most consistent questions we get at the show is from parents who want to know which episodes are kid-friendly and which aren't. So today, we're releasing a separate feed, Radiolab for Kids. To kick it off, we're rerunning an all-time favorite episode: Space. In the 60's, space exploration was an American obsession. This hour, we chart the path from romance to increasing cynicism. We begin with Ann Druyan, widow of Carl Sagan, with a story about the Voyager expedition, true love, and a golden record that travels through space. And astrophysicist Neil de Grasse Tyson explains the Coepernican Principle, and just how insignificant we are. Support Radiolab today at